Rhoen Klinikum AG (LTS:0NQH)

€ 12.15 0 (0%) Market Cap: 856.81 Mil Enterprise Value: 653.87 Mil PE Ratio: 18.66 PB Ratio: 0.65 GF Score: 78/100

Q3 2022 Rhoen Klinikum AG Earnings Call Transcript
Nov 10, 2022

€14.55

Earnings
Q3 2021 Rhoen Klinikum AG Earnings Call Transcript
Nov 11, 2021

€15.61

Earnings
Preliminary Q4 2020 Rhoen Klinikum AG Earnings Call Transcript
Feb 21, 2020

€16.98 (-2.13%)

Earnings
Q3 2019 Rhoen Klinikum AG Earnings Call Transcript
Nov 08, 2019

€19.01 (+4.28%)

Earnings
Preliminary 2018 Rhoen Klinikum AG Earnings Call Transcript
Feb 22, 2019

€24.74 (+0.16%)

Earnings

Q3 2022 Rhoen Klinikum AG Earnings Call Transcript

Nov 10, 2022 / 12:30PM GMT

Release Date Price: €14.55

Transcript

Julian Schmitt;N;KLINIKUM Aktiengesellschaft;Head of IR;Treasury;Stefan Stranz;N<

RHÃ;RHÃ

&

Dear investors and analysts. A warm welcome to everybody who has dialed in today. Our CFO, Dr. Stefan Stranz, will begin today's call with the key aspects of 2022. Afterwards, I will take over and share with you our financial figures for both 9M and fiscal year 2021. Dr. Stranz will continue with our outlook for 2022.

As always, we will close the conference call after a short Q&A session. Questions will be answered by Igor Levit, our Group Head of Accounting, Tax Controlling Finance and Investor Relations. Before we start, and according to the usual practice, I would like to draw your attention to the forward-looking statements and disclaimer wording on Page 2 of our presentation. This safe harbor language applies to the presentation, our guidance and all comments to be made today. Again, I would like to mention that everything will be recorded. And with that, I hand it over to Dr. Stranz.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.